Dr. Steven M. Abbate, MD

Dr. Abbate practices at South Texas Oncology and Hematology in San Antonio, Texas.

Dr. Abbate's NPI, 1235117433, was assigned on January 6, 2006. Dr. Abbate graduated from Mayo Clinic Alix School of Medicine - Rochester in 1996. Dr. Abbate holds Texas license M1442.

Dr. Abbate's primary practice is South Texas Oncology and Hematology, at 4383 Medical Dr, San Antonio, TX 78229 in Bexar County. The practice phone is (210) 593-2575.

Dr. Abbate's primary practice is South Texas Oncology and Hematology in San Antonio, Texas. Dr. Abbate is also affiliated with Methodist Hospital. The medical group on file is South Texas Oncology and Hematology. Dmand AI also links Dr. Abbate to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abbate practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Abbate's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Abbate is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Abbate's licenses on file in 2 states: Texas and Massachusetts.

Dmand AI lists abdominal hernia repair surgery, colon removal, esophagus, stomach, or upper small intestine surgery, gallbladder removal, groin hernia surgery, intestinal or bowel obstruction, mastectomy and thyroid surgery among the conditions Dr. Abbate treats.

CMS data shows 895 Medicare services from Dr. Abbate across 19 procedure codes in 2024, for 241 Medicare patients. Medicare paid $112,192 for them.

CMS counts 241 Medicare patients who saw Dr. Abbate in 2024. The largest group is 65 to 74, with 112 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abbate's median patient age at 70, with 65% women.

In 2024, Dr. Abbate wrote 807 Medicare Part D claims for 233 patients. 85% of them were for generic drugs. CMS names the drug for 743 of them, across 13 drugs with 11 or more claims each, at $311,902 in total drug cost. In 2023, CMS named 676 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Abbate for performance year 2024, reported as part of a group. Dr. Abbate accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abbate as offering telehealth.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Abbate. Dr. Abbate's most frequent co-authors are Maen Abdelrahim, MD, Alexey A. Aleshin, MD and Gregory P. Botta, MD, PhD.

CMS Open Payments shows 56 general payments to Dr. Abbate from 13 drug and device companies from 2017 to 2025. Education make up the largest share, 40% of the total. Intuitive Surgical, Inc. paid the most, $6,628.

Dr. Abbate graduated from Mayo Clinic Alix School of Medicine - Rochester in 1996.

Dr. Abbate is in network with 21 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.